Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Pharmacoepidemiology Office adds deputy

Executive Summary

Office of Drug Evaluation V Director Jonca Bull is moving to the Office of Pharmacoepidemiology & Statistical Science. Effective May 2, Bull is serving as deputy director, reporting to office Director Paul Seligman. The deputy director position was created in 2003 but had not been filled. ODE V is being dissolved as part of a reorganization of the Office of New Drugs; Bull was slated to move since the draft reorganization was finalized (1"The Pink Sheet" Oct. 25, 2004, p. 3)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045772

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel